Skip to main content
SpringerPlus

Table 2 The differences between responders and non responders at inclusion in the study (0 months of follow up)

From: Predictors of European League Against Rheumatism (EULAR) good response, DAS-28 remission and sustained responses to TNF-inhibitors in rheumatoid arthritis: a prospective study in refractory disease

Parameter

Responders (n = 56)

Non-responders (n = 24)

Significance

Mean ± S.D

Mean ± S.D

P-value

Age

47.84 ± 18.89

49.64 ± 15.70

P > 0.05

Disease duration

7.66 ± 4.11

6.59 ± 3.41

P > 0.05

Rheumatoid factor titers

169.95 ± 176.19

73.80 ± 74.58

P < 0.01**

ESR

51.40 ± 24.70

49.97 ± 26.93

P > 0.05

C-reactive protein

36.12 ± 34.27

33.10 ± 25.19

P > 0.05

Baseline-HAQ

1.25 ± 0.33

1.24 ± 0.34

P > 0.05

Baseline DAS-28

6.32 ± 0.62

5.34 ± 1.38

P < 0.01**

Baseline VAS

6.77 ± 0.97

6.51 ± 0.90

P > 0.05

Hemoglobin

11.59 ± 1.30

11.36 ± 1.06

P > 0.05

  1. *P-value: significant < 0.05. **P-value: highly significant < 0.01. Abbreviations: ESR: erythrocyte sedimentation rate, HAQ: health assessment questionnaire, DAS: disease activity score, VAS: visual analogue scale.
Back to article page